1. Company Information
incorporated in 2013,Anlon Healthcare Limited is a chemical manufacturing company, specialized in manufacturing of high purity advance pharmaceutical intermediates and Active Pharmaceutical Ingredients .
The Company serves as raw material for API in pharmaceutical formulations, nutritional ingredients nutraceuticals formulations, ingredients in personal care, and animal health products.
The Company is one of the few manufacturers of Loxoprofen Sodium Dihydrate, which is a notable API that is widely used in treatment of pain /inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.
The company products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
The company active pharmaceutical ingredient products are manufactured in accordance with Indian and international pharmacopeia standards such as IP, BP, EP, JP, USP.
In addition to manufacturing Pharma Intermediates and APIs to global standards, the company now offers custom manufacturing for complex chemicals, exceeding purity standards and reducing impurities to meet specific customer needs.
Products:
Pharma Intermediates:Cyanoethylbe nzoic acid, Ketonitrile and Methyldeslor atadine, these serve as a key starting material or as an advance intermediate for manufacturing of APIs.
Active Pharmaceutical Ingredients: The company’s APIs are key components in pharmaceutical products, delivering therapeutic effects. They are used in formulations like tablets, capsules, ointments, syrups, and in nutraceuticals, personal care, and veterinary products.
As of January 31, 2025, the company had 105 employees (excluding trainees) and 8 contract workers.
2. Competitive Strengths
1) Strong product portfolio and scalable business
2) Strong Promoters and Experienced Management Team
3) High entry and exit barriers due to long customer approval cycles and strict product standards
4) In-house Testing, Quality Control and Quality Assurancefor quality control
5) Focus on Quality, Environment, Health and Safety (QEHS
3. Anlon Healthcare IPO Registrar
Kfin Technologies Ltd.
Phone:04067162222, 04079611000
Email: ahl.ipo@kfintech.com
Website: https://ipostatus.kfintech.com/